ImExHS Limited (ASX:IME)
Australia · Delayed Price · Currency is AUD 0.3750
-0.0100 (-2.60%)
Jun 16, 2026, 3:03 PM AEST
ImExHS Market Cap
ImExHS has a market cap or net worth of 20.28 million as of June 16, 2026. Its market cap has increased by 4.58% in one year.
Market Cap
20.28M
Enterprise Value
17.54M
Revenue
28.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.38
Market Cap Chart
Since September 3, 2018, ImExHS's market cap has decreased from 24.99M to 20.28M, a decrease of -18.87%. That is a compound annual growth rate of -2.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 20.28M | -6.22% |
| Dec 30, 2025 | 21.62M | 25.63% |
| Dec 31, 2024 | 17.21M | -39.72% |
| Dec 29, 2023 | 28.55M | 50.42% |
| Dec 30, 2022 | 18.98M | -44.20% |
| Dec 31, 2021 | 34.01M | -28.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 402.20M |
| Monash IVF Group | 266.90M |
| Healius | 261.41M |
| Cryosite | 51.74M |
| INOVIQ | 44.34M |
| Rhythm Biosciences | 38.93M |
| Microba Life Sciences | 28.01M |
| BCAL Diagnostics | 25.81M |